AnaptysBio, Inc. (ANAB)
NASDAQ: ANAB · Real-Time Price · USD
55.16
-0.54 (-0.97%)
At close: Sep 10, 2026, 4:00 PM EDT
54.39
-0.77 (-1.40%)
After-hours: Sep 10, 2026, 5:36 PM EDT
AnaptysBio Stock Forecast
Stock Price Forecast
According to 8 analysts polled by S&P Global, AnaptysBio stock has a consensus rating of "Strong Buy" and an average price target of $89.63. The average 1-year stock price forecast is 62.49% higher than the current stock price, while the lowest is $70 (+26.90%) and the highest is $140 (+153.81%).
Price Target: $89.63 (+62.49%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for AnaptysBio stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 7 | 8 | 8 | 8 | 8 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 1 | 1 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 11 | 11 | 11 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Aug 24, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $95 | Buy | Reiterates | $95 | +72.23% | Aug 24, 2026 |
| Barclays | Barclays | Buy Maintains $75 | Buy | Maintains | $75 | +35.97% | Jul 31, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $93 | Buy | Maintains | $93 | +68.60% | Jul 21, 2026 |
| UBS | UBS | Buy Maintains $76 | Buy | Maintains | $76 | +37.78% | Jul 1, 2026 |
Financial Forecast
Revenue This Year
105.72M
from 234.60M
Decreased by -54.94%
Revenue Next Year
172.18M
from 105.72M
Increased by 62.86%
EPS This Year
-0.23
from -0.46
EPS Next Year
5.24
from -0.23
EPS and Forward PE are based on non-GAAP adjusted numbers.